MétaCan
Menu
Back to cohort
Record W2325006048 · doi:10.1093/eurheartj/eht309.3689

Impact of a budget-restrictive (Germany) versus an incentive-driven (UK) reimbursement system on LDL-goal-achievement in statin-treated patients for secondary prevention: results of DYSIS

2013· article· en· W2325006048 on OpenAlexaboutno aff
Anselm K. Gitt, Claus Juenger, W. Smolka, D Wood, J. Kastelein

Bibliographic record

VenueEuropean Heart Journal · 2013
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicHealth Systems, Economic Evaluations, Quality of Life
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineReimbursementDyslipidemiaStatinAtorvastatinRosuvastatinPhysical therapyInternal medicineDiseaseHealth care

Abstract

fetched live from OpenAlex

Background: Statin treatment is widespread used for secondary prevention in Europe. However, there are large differences in LDL-Cholesterol (LDL-C) target achievement between European countries. Little is known about the impact of different reimbursement systems on achievement of lipid targets in clinical practice. Methods: Between June 2008 and February 2009, 22,063 consecutive statin-treated outpatients were enrolled in 11 European countries and Canada (DYSIS = Dyslipidemia International Study) to assess LDL-C target achievement for secondary prevention. In outpatient treatment in Germany chronic medical treatment is restricted by budget constraints (restrictive system) whereas in the UK reimbursement is linked to treatment goal achievements (incentive system). We compared the level of LDL-C goal achievement in patients enrolled in Germany versus the UK. Results: A total of 4,260 patients were enrolled in Germany, 540 patients in the UK. Patients in Germany were older, more often female, more often had diabetes, less often were obese and less often reported sedentary lifestyle. They had a higher prevalence of cerebrovascular and peripheral artery disease but less often ischemic heart disease as compared to the patients in the UK. Patients in Germany (with a restrictive reimbursement system) less often received potent statins such as atorvastatin or rosuvastatin as compared to patients in the UK. Independent of the statin used, daily dosages were significantly lower in Germany than in the UK. As a result, significantly less patients in Germany did reach the recommended treatment goal of LDL-C <100mg/dl as compared to the UK (42.0% in Germany versus 79.8% in the UK). Conclusion: In Germany, patients treated with statins for secondary prevention received less potent statins and lower dosages as compared to the UK probably due to differences in reimbursement systems (restrictive versus incentive). This led to a much worth LDL-C goal achievement in Germany as compared to the UK.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.012
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.016
Threshold uncertainty score0.036

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0070.012
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0020.001
Open science0.0010.002
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.207
GPT teacher head0.418
Teacher spread0.210 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations10
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Heart JournalSame topicHealth Systems, Economic Evaluations, Quality of LifeFrench-language works237,207